PlainRecalls
FDA Drug Moderate Class II Terminated

PGE 20 mcg/mL Injectable, 10 mL, and PGE 40 mcg/mL, 5 mL, Rx Only, The Compounding Center at Blue Ridge, 2601 Blue Ridge Rd, Raleigh, NC 27607.

Reported: January 15, 2014 Initiated: October 18, 2013 #D-402-2014

Product Description

PGE 20 mcg/mL Injectable, 10 mL, and PGE 40 mcg/mL, 5 mL, Rx Only, The Compounding Center at Blue Ridge, 2601 Blue Ridge Rd, Raleigh, NC 27607.

Reason for Recall

Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Details

Units Affected
11 units
Distribution
NC
Location
Raleigh, NC

Frequently Asked Questions

What product was recalled?
PGE 20 mcg/mL Injectable, 10 mL, and PGE 40 mcg/mL, 5 mL, Rx Only, The Compounding Center at Blue Ridge, 2601 Blue Ridge Rd, Raleigh, NC 27607.. Recalled by Compounding Centre At Blue Ridge. Units affected: 11 units.
Why was this product recalled?
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 15, 2014. Severity: Moderate. Recall number: D-402-2014.